Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	MACHOVÁ POLÁKOVÁ Kateřina NÁDVORNÍKOVÁ Sylvie ZEMANOVÁ Karla KLAMOVÁ Hana JURČEK Tomáš DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela MAYER Jiří TRNĚNÝ Marek MORAVCOVÁ Jana
Year of publication	2010
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies